EASL Policy Statements
EASL Policy Statements
The policy statements are designed to influence and determine decisions and actions within the scope of coverage. The EASL Policy Statements are related to the burden of liver disease in Europe. They aim to describe the epidemiology and analysis of risk factors to identify the best public health interventions that could impact these risk factors to reduce the burden of liver disease.
Download the EASL Guidelines App
- Consult EASL CPGs anytime, anywhere.
- Enhance your clinical decision-making with calculators and score.
- Expand your knowledge with continuously updated resources and tools.
- Viral hepatitis
Hepatitis E is an infectious inflammation of the liver caused by the hepatitis E virus (HEV).
Full version of Policy Statement…
Full version of Policy Statement…
- General hepatology
The current system of providing healthcare to asylum seekers and migrants is failing, resulting in unnecessary prevalence of liver disease, infection with hepatitis viruses and alcohol abuse.
Full version of Policy Statement…
Full version of Policy Statement…
- Viral hepatitis
Viral hepatitis is an inflammatory condition of the liver and the7th most frequent cause of death in the world, surpassing HIV
Full version of Policy Statement…
Full version of Policy Statement…
- Metabolism, alcohol and toxicity
Prevalence of NAFLD continues to rise and is now becoming one of the most frequent causes of cirrhosis (advanced liver disease) and liver transplantation in Europe
Full version of Policy Statement…
Full version of Policy Statement…
- Metabolism, alcohol and toxicity
Alcohol-related Liver Disease (ARLD) is the major cause of liver disease in Europe and, since it depends mostly on harmful alcohol consumption, it is a highly preventable disease.
Full version of Policy Statement…
Full version of Policy Statement…
- Hepatitis C
WHO has set a goal of eliminating the hepatitis C virus (HCV) by 2030 but the achievement of this goal is challenged by people who inject drugs (PWID), who account for most of the new cases of HCV infection in high-income countries.
In order to achieve the 2030 WHO viral…
In order to achieve the 2030 WHO viral…
- General hepatology
This policy statement is intended for the general public, affected communities, and policymakers. In parallel, intended for healthcare professionals, an […]
…- Liver tumours, Metabolism, alcohol and toxicity
Geneva, 27 May 2022: In Europe, the number of deaths from liver cancer has doubled in the past 30 years. […]
…- General hepatology
Stigma and discrimination fuel health disparities and worsen outcomes for individuals with liver disease. To address these challenges, we must shift the focus from individual blame to the broader social determinants of health. Learning from successful approaches in HIV, mental health, diabetes, and cancer, we must implement targeted interventions that…
- Metabolism, alcohol and toxicity
Alcohol-related Liver Disease (ARLD) is the major cause of liver disease in Europe and, since it depends mostly on harmful alcohol consumption, it is a highly preventable disease.
Full version of Policy Statement…
Full version of Policy Statement…